Allogene Therapeutics Updates Officer Compensation
Allogene Therapeutics files 8-K on officer compensatory arrangements. The filing discloses changes to executive pay.
Filed: 2026-05-28 AccNo: 0001193125-26-245484 Size: 140 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers